Paper41520198
The role of pharmacogenomics in personalized medicine.
Božina N and 1 other. Croat Med J, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. The role of pharmacogenomics in personalized medicine. Papers, record 41520198. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41520198
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27449638 | Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors. | Drug Saf | 2016 | https://conductscience.org/library/papers/27449638 | PubMed |
| 2 | 29735005 | Adverse Drug Reactions (ADR) and Emergencies. | Dtsch Arztebl Int | 2018 | https://conductscience.org/library/papers/29735005 | PubMed |
| 3 | 36739136 | A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. | Lancet | 2023 | https://conductscience.org/library/papers/36739136 | PubMed |
| 4 | 31696505 | Global Pharmacogenomics Within Precision Medicine: Challenges and Opportunities. | Clin Pharmacol Ther | 2020 | https://conductscience.org/library/papers/31696505 | PubMed |
| 5 | 15037866 | Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. | Mol Psychiatry | 2004 | https://conductscience.org/library/papers/15037866 | PubMed |
| 6 | 14748810 | Adverse drug reactions in elderly patients. | Br J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/14748810 | PubMed |
| 7 | 16056390 | Pharmacogenetics-based therapeutic recommendations--ready for clinical practice? | Nat Rev Drug Discov | 2005 | https://conductscience.org/library/papers/16056390 | PubMed |
| 8 | 39953671 | A Comprehensive CYP2D6 Drug-Drug-Gene Interaction Network for Application in Precision Dosing and Drug Development. | Clin Pharmacol Ther | 2025 | https://conductscience.org/library/papers/39953671 | PubMed |
| 9 | 41520206 | Pharmacogenomics in the prediction of adverse effects of cardiovascular drugs: the PGx-CardioDrug project. | Croat Med J | 2026 | https://conductscience.org/library/papers/41520206 | PubMed |
| 10 | 15231615 | Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. | BMJ | 2004 | https://conductscience.org/library/papers/15231615 | PubMed |
| 11 | 35194175 | Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review. | Pharmacogenomics J | 2022 | https://conductscience.org/library/papers/35194175 | PubMed |
| 12 | 41276480 | Pharmacogenomics-guided personalized medicine in a clinical setting: real-world data. | Pharmacogenet Genomics | 2026 | https://conductscience.org/library/papers/41276480 | PubMed |
| 13 | 40552566 | Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE Study. | Clin Pharmacol Ther | 2025 | https://conductscience.org/library/papers/40552566 | PubMed |
| 14 | 39791881 | Pharmacogenetic guided drug therapy - how to deal with phenoconversion in polypharmacy. | Expert Opin Drug Metab Toxicol | 2025 | https://conductscience.org/library/papers/39791881 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42898243 | Liver enzyme elevations during statin-ezetimibe therapy in ABCG2 c.421C>A variant carriers: a case series and narrative review. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42898243 |
Source PubMed
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB6 | 10058 | PubTator's text mining | https://conductscience.org/library/genes/10058 | NCBI Gene |
| CYP4F3 | 4051 | PubTator's text mining | https://conductscience.org/library/genes/4051 | NCBI Gene |
| PPIG | 9360 | PubTator's text mining | https://conductscience.org/library/genes/9360 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41520198
GET https://conductscience.org/api/papers/v1/41520198/authors